Latest news with #AZO
Yahoo
4 days ago
- Automotive
- Yahoo
Jim Cramer Says to 'Just Go Buy It' AutoZone, Inc. (AZO) Stock
We recently published a list of . In this article, we are going to take a look at where AutoZone, Inc. (NYSE:AZO) stands against other stocks that Jim Cramer discusses. Cramer started his game plan for this week with AutoZone, Inc. (NYSE:AZO) as he commented: 'We have some high-profile companies reporting on Tuesday. Now we start with one of the top performers of the year, and that's a company called AutoZone, AZO. This auto parts chain has been on fire, and it doesn't hurt that AutoZone has one of the most aggressive buybacks I have ever seen. They've more than cut half of the stock… in the last decade. If the stock gets hit, please do this, you should just go buy it because management will be right there alongside you buying it after a few days. What a horse.' A technician in a mechanic's uniform replacing an A/C compressor, signifying the company's automotive replacement parts business. AutoZone, Inc. (NYSE:AZO) provides a wide range of automotive replacement parts and accessories. The company's products include hard parts, maintenance supplies, and items unrelated to vehicles. Overall, AZO ranks 1st on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of AZO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AZO and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
New York Post
4 days ago
- Health
- New York Post
Over-the-counter drug for condition that 15M women get a year is linked to cancer
As if urinary tract infections weren't bad enough, a new report claims that a popular over-the-counter drug used to treat UTI symptoms has been linked to cancer concerns. UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and discomfort associated with UTIs. But this medication has not been formally approved by the Food and Drug Administration — and research has raised concerns about its potential cancer risk, Bloomberg reported. 3 AZO works by numbing the lining of the urinary tract. ColleenMichaels – Phenazopyridine, first synthesized in 1914, works by numbing the lining of the urinary tract to relieve UTI symptoms. Bloomberg reported that phenazopyridine was marketed before current FDA regulations for drug approval were in place. Because of its long history, it was essentially 'grandfathered in' and remains on the market without full FDA approval. One concern about phenazopyridine is that it can mask the symptoms of a UTI, potentially delaying antibiotic treatment. There are also potential risks associated with high doses or prolonged use. A 2021 study conducted by the National Institutes of Health (NIH) found that dietary exposure to phenazopyridine caused tumors in two rodent species at two different tissue sites. In female mice, phenazopyridine caused benign and malignant liver tumors. In rats of both sexes, it caused benign or malignant colorectal tumors. The NIH noted that while the animal studies don't explicitly prove a link between human exposure to phenazopyridine and the development of cancer, the drug is 'reasonably anticipated to be a human carcinogen.' 3 UTIs are among the most common infections worldwide, affecting 50% to 60% of women. 9nong – Side effects of phenazopyridine include chest tightness, dizziness, lethargy, loss of appetite and stomach pain. More severe, though less common, reported reactions include depression, muscle twitching, kidney failure, seizures and nose bleeds. In rare cases, phenazopyridine can cause death due to methemoglobinemia, a condition that interferes with the blood's ability to carry oxygen. While phenazopyridine is available OTC in the US, it requires a prescription in Canada and the UK. 3 Symptoms of a UTI include the urgent need to urinate, a burning sensation when peeing, pressure or pain in the lower abdomen or pelvic region, cloudy or blood-tinged urine and urine with a strong odor. sirichai – UTIs begin when bacteria enter the urethra and infect the urinary tract due to genetic disposition, sexual activity or poor hygiene. Symptoms include the urgent need to urinate, a burning sensation when peeing, pressure or pain in the lower abdomen or pelvic region, cloudy or blood-tinged urine and urine with a strong odor. Antibiotics are the primary cure for UTIs as they eliminate the bacteria that cause the infection. However, many patients use phenazopyridine to manage symptoms while they await antibiotics. Unfortunately, studies indicate that the bacteria that cause UTIs are becoming more resistant to antibiotics, making these infections more dangerous than ever. Part of this resistance can be attributed to meat consumption, as animals treated with antibiotics can develop resistance to those drugs that's transferred to humans. And UTIs seem to be becoming more prevalent. Recent research found the global disease burden of UTIs rose by more than 68% between 1990 and 2019. Increased rates of UTIs can be attributed to several factors, including a growing population, particularly an elderly one that is more susceptible to UTIs, and a swath of sexually active young people. But relief may be on the way. In March, the FDA approved the antibiotic Blujepa to treat uncomplicated UTIs in women 12 and older. The drug acts on a different part of the bacteria compared to most other antibiotics, making it effective against organisms resistant to current treatments.
Yahoo
4 days ago
- Automotive
- Yahoo
TD Cowen Keeps Buy Rating on AutoZone (AZO), Sees Good Potential
On Wednesday, May 28, TD Cowen reaffirmed a 'Buy' rating on AutoZone, Inc. (NYSE:AZO) with a price target of $4,300. TD Cowen analyst, Max Rakhlenko, emphasized that the company is performing well despite some short-term challenges. The analyst discussed the company's domestic comparable sales, which grew by 5% in the most recent quarter, supported by growth in both the do-it-for-me (DIFM) and do-it-yourself (DIY) segments. A technician in a mechanic's uniform replacing an A/C compressor, signifying the company's automotive replacement parts business. AutoZone, Inc.'s (NYSE:AZO) recently reported Q3 results, which were mixed. While domestic sales growth was impressive, the company faced margin pressures caused by one-time factors and strategic long-term investments. According to Rakhlenko, these investments are expected to impact margins in the short term only and margins should return to normal in future quarters. The analyst also pointed out the potential for AutoZone, Inc. (NYSE:AZO) to benefit from these strategic initiatives as they mature. Additionally, Rakhlenko noted that the company is well-positioned to benefit from the likely inflation trends and the opportunities to grow its market share. The analyst believes that AutoZone, Inc. (NYSE:AZO) is making strategic decisions, which will be beneficial in the long run. AutoZone, Inc. (NYSE:AZO) is an American company that specializes in aftermarket automotive parts. It is the leading retailer and distributor of automotive replacement parts and accessories in the US. While we acknowledge the potential of AZO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AZO and that has a 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Automotive
- Yahoo
TD Cowen Keeps Buy Rating on AutoZone (AZO), Sees Good Potential
On Wednesday, May 28, TD Cowen reaffirmed a 'Buy' rating on AutoZone, Inc. (NYSE:AZO) with a price target of $4,300. TD Cowen analyst, Max Rakhlenko, emphasized that the company is performing well despite some short-term challenges. The analyst discussed the company's domestic comparable sales, which grew by 5% in the most recent quarter, supported by growth in both the do-it-for-me (DIFM) and do-it-yourself (DIY) segments. A technician in a mechanic's uniform replacing an A/C compressor, signifying the company's automotive replacement parts business. AutoZone, Inc.'s (NYSE:AZO) recently reported Q3 results, which were mixed. While domestic sales growth was impressive, the company faced margin pressures caused by one-time factors and strategic long-term investments. According to Rakhlenko, these investments are expected to impact margins in the short term only and margins should return to normal in future quarters. The analyst also pointed out the potential for AutoZone, Inc. (NYSE:AZO) to benefit from these strategic initiatives as they mature. Additionally, Rakhlenko noted that the company is well-positioned to benefit from the likely inflation trends and the opportunities to grow its market share. The analyst believes that AutoZone, Inc. (NYSE:AZO) is making strategic decisions, which will be beneficial in the long run. AutoZone, Inc. (NYSE:AZO) is an American company that specializes in aftermarket automotive parts. It is the leading retailer and distributor of automotive replacement parts and accessories in the US. While we acknowledge the potential of AZO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AZO and that has a 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio
Yahoo
5 days ago
- Business
- Yahoo
AZO Q2 Earnings Call: Sales Growth Driven by Commercial Segment, Margin Pressure from Investments and FX
Auto parts and accessories retailer AutoZone (NYSE:AZO) fell short of the market's revenue expectations in Q2 CY2025, but sales rose 5.4% year on year to $4.46 billion. Is now the time to buy AZO? Find out in our full research report (it's free). Operating Margin: 19.4%, down from 21.3% in the same quarter last year Locations: 7,516 at quarter end, up from 7,236 in the same quarter last year Same-Store Sales rose 3.2% year on year (1.9% in the same quarter last year) Market Capitalization: $61.81 billion AutoZone's second quarter results were shaped by notable strength in its commercial segment and steady execution in core retail operations. Management attributed the company's 5.4% sales growth to improved commercial sales execution, expansion of hub and MegaHub store formats, and ongoing share gains in both retail (DIY) and commercial markets. CEO Phil Daniele emphasized that initiatives around parts availability, delivery speed, and product assortment have begun to yield market share gains, particularly in domestic commercial sales, which grew at a double-digit rate. CFO Jamere Jackson provided additional context, noting that commercial program expansion and investments in supply chain infrastructure underpinned the quarter's top-line performance, despite ongoing pressure in discretionary categories and negative foreign currency impacts. Looking ahead, AutoZone's leadership anticipates continued top-line momentum as commercial initiatives mature and international expansion accelerates. Management stated that investments in new distribution centers, hub and MegaHub store growth, and technology should bolster inventory availability and customer service, positioning the company for further share gains. However, CFO Jamere Jackson cautioned that margin pressures may persist in the near term, citing higher supply chain costs, self-insurance expenses, and potential tariff impacts. CEO Phil Daniele reinforced the company's commitment to disciplined expense management and strategic investment, saying, 'We are in the early innings of our growth initiatives, and while expenses are elevated, these investments are expected to drive faster top-line and earnings growth over time.' Management identified commercial segment expansion, regional performance shifts, and increased investment in supply chain and technology as key drivers of the quarter's results and near-term outlook. Commercial segment momentum: The domestic commercial business delivered over 10% sales growth, driven by expanded product assortment, improved delivery speed, and the rollout of new hub and MegaHub stores. Management highlighted these initiatives as the primary contributors to recent share gains and consistent transaction growth in commercial accounts. Retail (DIY) traffic improvement: DIY segment traffic increased 1.4% after previous declines, signaling stabilization and market share gains, especially in maintenance and failure categories. Management noted that discretionary categories remain soft due to cautious consumer spending, but core maintenance demand is compensating for this weakness. Regional performance shifts: The Northeast and Rust Belt regions outperformed other markets for the first time in several quarters, benefiting from colder winter and favorable spring weather. Meanwhile, South Central and Western regions experienced comparatively slower growth, with management attributing the differences to weather patterns and pent-up seasonal demand. International expansion and FX headwinds: AutoZone opened 30 new stores internationally, maintaining strong same-store sales growth on a constant currency basis. However, significant foreign exchange headwinds, particularly in Mexico, negatively impacted reported sales, operating profit, and EPS. Management expects these currency pressures to persist in the near term. Elevated investment in growth initiatives: The company continued accelerated investment in supply chain, store expansion, and technology, leading to higher SG&A costs. CFO Jamere Jackson explained that these investments are essential for long-term growth, but currently weigh on operating margins as the benefits are realized over several quarters. AutoZone expects its commercial initiatives, international growth, and investment in supply chain infrastructure to drive future revenue, while margin headwinds from expenses, FX, and tariffs remain a focus. Commercial and international expansion: Management believes that continued rollout of hub and MegaHub locations, combined with aggressive store openings in both domestic and international markets, will sustain above-market sales growth and expand the company's reach. CEO Phil Daniele highlighted opportunities to gain share in underpenetrated commercial and international regions. Margin management amid higher expenses: CFO Jamere Jackson cautioned that operating margin will remain pressured in the short term due to ongoing investment in distribution centers, higher self-insurance costs, and an unfavorable sales mix as commercial growth outpaces retail. Management expects some cost headwinds to abate over time but stressed the need for disciplined SG&A growth as expansion continues. Tariff and inflation uncertainty: Management is monitoring evolving tariff policies and inflation trends, noting that while recent tariff impacts have been modest, future cost increases could require a combination of vendor negotiations, sourcing shifts, and selective price adjustments to protect margins. The company expects to offset tariff-related costs but acknowledged that supply chain inflation could affect pricing and profitability. Looking forward, the StockStory team will be monitoring (1) the pace and profitability of new hub and MegaHub store openings, (2) stabilization of operating expenses as distribution center and technology investments mature, and (3) the company's ability to offset FX and tariff-related headwinds through pricing and sourcing strategies. Execution on commercial and international expansion, as well as sustained share gains in both retail and commercial channels, will be key signposts for progress. AutoZone currently trades at a forward P/E ratio of 22.3×. At this valuation, is it a buy or sell post earnings? See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
